Squarepoint Ops LLC Merus N.V. Transaction History

Squarepoint Ops LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$11.34 - $19.44 $322,793 - $553,359	-28,465 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$14.08 - $18.5 $400,787 - $526,602	28,465 New	28,465 $401,000
Q2 2019 Aug 14, 2019	SELL	$12.93 - $16.83 $144,816 - $188,495	-11,200 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$11.09 - $15.83 $6,654 - $9,498	-600 Reduced 5.08%	11,200 $165,000
Q4 2018 Feb 14, 2019	BUY	$11.46 - $20.81 $12,606 - $22,891	1,100 Added 10.28%	11,800 $165,000
Q3 2018 Nov 14, 2018	BUY	$18.47 - $26.39 $197,629 - $282,373	10,700 New	10,700 $211,000

200

61.9M

243K

300K

Ticker MRUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,878,200
Market Cap $2.04B
Description
Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.